[HTML] frontiersin.org

[HTML][HTML] Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

MP Barr, KJ O'byrne, K Gately - Frontiers in oncology, 2013 - frontiersin.org
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …
被引用次数：327 相关文章

[引用][C] Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr… - Frontiers in …, 2013 - cir.nii.ac.jp
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr… - Frontiers in …, 2013 - pubmed.ncbi.nlm.nih.gov
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …
[PDF] core.ac.uk

[PDF][PDF] Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr, KJ O'Byrne… - core.ac.uk
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …
[PDF] scienceopen.com

[PDF][PDF] Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr, KJ O'Byrne… - scienceopen.com
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …
[PDF] cyberleninka.org

[PDF][PDF] Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr, KJ O'Byrne… - cyberleninka.org
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …
[PDF] researchgate.net

[PDF][PDF] Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr, KJ O'Byrne… - researchgate.net
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr… - Frontiers in …, 2013 - eprints.qut.edu.au
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …
[HTML] nih.gov

[HTML][HTML] Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

P Godwin, AM Baird, S Heavey, MP Barr… - Frontiers in …, 2013 - ncbi.nlm.nih.gov
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

P Godwin, AM Baird, S Heavey, MP Barr… - Frontiers in …, 2013 - europepmc.org
Intrinsic or acquired resistance to chemotherapeutic agents is a common phenomenon and
a major challenge in the treatment of cancer patients. Chemoresistance is defined by a …